Skip to content

Do broadly neutralising antibodies really have a future in treating HIV?

thekopmylife/Shutterstock.com

A cure must be a cure for all: why more HIV cure research in Africa is needed

Nurse explaining the study product to a participant for the first clinical trial at FRESH. Image by Dr Krista Dong, FRESH Clinical Research Site.

Repeated infusions of two antibodies delay viral rebound but don’t prevent it

Wongsakorn Napaeng/Shutterstock.com

Top 5 HIV treatment stories from CROI 2022

Professor Samir Gupta (top right) presenting a study on lenacapavir at CROI 2022.

Top 5 HIV cure and vaccine stories from CROI 2022

Professor Yvonne Bryson (top centre) presenting the HIV remission case at CROI 2022.

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

Dr Boris Juelg (bottom left) and Dr Marina Caskey (bottom right) at CROI 2022.

One person remains undetectable without HIV drugs almost four years after using an antibody-based therapy

Dr Ole Schmeltz Søgaard at CROI 2022.

Could antibodies be used for children with HIV instead of pills?

Dr Roger Shapiro at CROI 2022.

Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade

Image by UNAMID. Creative Commons licence.